Aurobindo pharma products. 7% in Q3FY26, an improvem...
- Aurobindo pharma products. 7% in Q3FY26, an improvement of 129 basis points year-over-year, reflecting efficient cost management and favorable product mix. , has successfully obtained New Drug Application (NDA) approval from the U. Aurobindo Pharma emphasized that there has been no impact on its financial position, manufacturing operations, or other business activities as a result of the inspection and the observations issued. S. com The entry of Aurobindo Pharma into the Philippines is a strong vote of confidence in the country’s growing pharmaceutical market partly due to the expanding healthcare coverage under the Get a list of all medicines and other products manufactured by Aurobindo Pharma Ltd. Aurobindo Pharma Ltd Q3 2025 Earnings Call Transcript Published Feb 07, 2025 21 pages (10826 words) — Published Feb 07, 2025 Price US$ 54. Aurobindo Pharma Ltd is engaged in manufacturing semi synthetic penicillin (SSPs). The company maintains no material financial impact and will appeal the decision, citing pending Writ . Aurobindo Pharma Ltd (BOM:524804) reported an 8. Hyderabad-based pharmaceutical giant Aurobindo Pharma Ltd. The company demonstrated sustained business momentum across key segments. 69 Aurobindo Pharma plans to expand its product portfolio with high-value products in oncology, hormones, biosimilars, and novel drug delivery solutions like depot injections, inhalers, patches, and films. The stock price of the pharmaceutical company was quoting at its Aurobindo Pharma CFO Santhanam Subramanian and Acrotech Biopharma CEO Ashish Anvekar outline margin focus, Pen-G ramp-up and US FDA approval growth plans. Aurobindo Pharma Limited manufactures, markets and/or distributes more than 311 drugs in the U. 10. Featuring the wide range of medicines marketed by Aurobindo Pharma Ltd, ensuring trust and reliability in every product. Explore our global leadership in the industry. Acrotech Biopharma Inc (“Acrotech”) a step-down subsidiary of Aurobindo Pharma Ltd, India was formed as a global platform to commercialize innovative proprietary medications. 84 crore GST demand from the Additional Commissioner of Central Tax, Ranga Reddy GST Commissionerate, over alleged erroneous ITC refunds from its EOU Unit 3 during September-December 2022. is a generic pharmaceutical manufacturer and distributor and is a wholly owned subsidiary of Aurobindo Pharma Limited, a leading generic pharmaceutical company based in India. The pharmaceutical company stated that routine regulatory inspections are part of Aurobindo Pharma shares fell after the US FDA flagged nine issues at a Telangana plant. Aurobindo Pharma Limited is an integrated global pharmaceutical company headquartered in Hyderabad, India, with operations spanning over 150 countries. 91 crore towards Aurobindo Pharma Limited is an integrated global pharmaceutical company headquartered in Hyderabad, India. “For pharma, companies with robust domestic chronic portfolios, biosimilars, and peptide pipelines are poised to outperform the broader IPM. Market participants are now closely watching the company’s response and any subsequent action from the US regulator. The company reported a gross margin of 59. Products Sapropterin Dihydrochloride Tablets 100 mg – 120/Bottle Avinash Badavath KUVAN® Aug 19, 2024 · $75. [Form 483 Observations]: Aurobindo Pharma's stock is sliding due to observations at Unit 7, including inadequate quality investigations, improperly identified root causes, and unjustified out-of-specification results. The pharmaceuticals that were donated have been sent with partner organizations to continents all over the world in more than 19 countries. The company confirmed it had previously disclosed the inspection completion on February 10, 2026, and emphasized its compliance with SEBI disclosure regulations. 4% year-on-year to ₹8,646 crores. FDA Approval for ADQUEY™ (Difamilast 1%) Granted Aurobindo Pharma Limited has confirmed that its subsidiary, Acrotech Biopharma Inc. Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1390 in its research report dated February 10, 2026. The total disputed amount includes ₹84. Leverage your professional network, and get hired. Aurobindo Pharma faces a ₹169. Known for its broad product portfolio spanning generic, biosimilar, and specialty drugs, the company has established a resilient presence through aggressive R&D, strategic acquisitions, and compliance with regulatory Aurobindo Pharma on Monday said its consolidated net profit increased 8 per cent year-on-year to Rs 910 crore for the December quarter, led by robust sales in Europe and the US. Aurobindo Pharma Limited is a global marketer and manufacturer of generic pharmaceuticals and active pharmaceutical ingredients. District Courts. Aurobindo Pharma share price rebounds 3% after USFDA inspection clarification; brokerages flag OAI risk but see limited earnings impact, maintain positive long-term outlook. The shares of Aurobindo Pharma will be in focus in today's session, as the USFDA issued a Form 483 with a total of nine observations post the inspection. Coli and bird droppings in systems. 92 crore in GST and an equal penalty. aurobindo pharma limited visakapatanamu Blogs, Comments and Archive News on Economictimes. 55, falling 8 per cent on the BSE in Tuesday’s intra-day trade after the company announced December 2025 quarter (Q3FY26) results on Monday after market hours. Aurobindo Pharma's stock faced significant selling pressure, declining nearly 5% on February 18, 2026, after reports emerged detailing serious observations from the U. Aurobindo Pharma has received nine observations from the US Food and Drug Administration (USFDA) following an inspection of its Unit 7 manufacturing facility in Jedcherla, Telangana, highlighting gaps in quality systems, documentation, and data integrity at a plant central to its US generics business. Find out what it means for compliance, investors, and the stock outlook. Learn more Strength in […] Explore Aurobindo Pharma’s wide range of high-quality pharmaceutical products trusted worldwide for reliability, innovation, and global healthcare excellence. Aurobindo Pharma said on Thursday, February 19, that it has received tax demand orders totalling ₹169. Food and Drug Administration (FDA). 1mg. Q3 results 2026: BSE, Zydus Lifesciences, Aurobindo Pharma, Bajaj Electricals, Bata India, Happiest Minds Technologies, Navin Fluorine International, P N Gadgil Jewellers, Sun Pharma, among Gels are semisolid system in which a liquid phase is constrained within a 3-D polymeric matrix (consisting of natural or synthetic gum) having a high degree of physical or chemical cross-linking. The company has a product presence in key therapeutic segments like SSPs, cephalosporins, antivirals, CNS, cardio Aurobindo Pharma Share Price - Get Aurobindo Pharma LIVE BSE/NSE stock price with Performance, Fundamentals, Market Cap, Share holding, financial report, company profile, annual report, quarterly results, profit and loss Financial Health and Outlook Aurobindo Pharma's financial health remains robust, supported by disciplined capital allocation and strong cash flow generation. Aurobindo is a global pharmaceutical company with a broad portfolio of generic drugs that includes more than 180 product families and 450 individual product packages. United States Aurobindo Pharma Usa Company export History Records. Aurobindo Pharma USA stands out as a significant player within the specialized and highly competitive US pharmaceutical market. The pharmaceutical major has responded to stock exchange queries regarding media coverage of regulatory activities and inspections at its manufacturing operations. Aurobindo Pharma share price: The US FDA reportedly found that the equipment was not cleaned for years at the plant, with presence of E. Our Products Filter alphabetically A B C D E F G H I L M N O P Q R S T U V Z Therapeutic Class Brand Equivalent Product Form Sort by Aurobindo Generic Name Brand Name Browse the complete list of Aurobindo Pharma products including APIs, formulations, and therapeutic solutions available across global markets. New Naidupeta Aurobindo Pharma jobs added daily. Aurobindo Pharma USA, Inc. Food and Drug Administration (USFDA) at its Unit-7 manufacturing facility in Telangana. Today’s top 10 Naidupeta Aurobindo Pharma jobs in United States. HSBC has a buy on Aurobindo Pharma with the target price raised to Rs 1,415. The shares had rebounded sharply after hitting a 52-week low of ₹1,010 last year, later touching a high of ₹1,278. Synopsis: Aurobindo Pharma Limited shares fell nearly 5% after the USFDA issued a Form 483 citing quality, contamination, and data integrity concerns at its Telangana Unit-VII facility. com helps its user by providing a complete list of product manufacture by Aurobindo Pharma Ltd The company launched 6 new products and received 7 final approvals in the U. The Hyderabad-based company, in an exchange filing, said the FDA inspected Aurobindo Pharma’s Unit-VII, an oral solid dosage manufacturing unit Historically, Aurobindo Pharma has demonstrated strong operational execution and a diversified product portfolio, which helped the stock recover from previous lows. aurobindo pharma limited visakapatanamu Latest Breaking News, Pictures, Videos, and Special Reports from The Economic Times. The company's product portfolio is spread over major therapeutic/product areas encompassing Antibiotics, AntiRetrovirals, CVS, CNS, Systemic Gastroenterologicals, Anti-Allergies, Anti-Diabetics and other therapeutic Comprehensive range of WHO-approved generic ARV medicines, including fixed-dose combinations for HIV treatment in 100+ countries. Find the complete list of products marketed by Aurobindo Pharma Ltd. Explore Aurobindo's comprehensive pharmaceutical business - from active ingredients to finished dosages, serving patients in 150+ countries with quality medicines. Headquartered in HITEC City, Hyderabad, India, founded in 1986 and becoming a public company in India in 1992. Explore our global manufacturing excellence and trusted pharmaceutical products. The company aims to launch scientifically advanced products to address unmet needs and deliver value to patients as well as all healthcare stakeholders. Lupin and Aurobindo Pharma are particularly well-positioned with strong US product performance, successful launches, and market-leading operations in India,” said the brokerage. Aurobindo Pharma provides high-quality generics, APIs & biosimilars to enhance global healthcare. Aurobindo Pharma has received official demands to return over Rs 169 crore following a dispute regarding the alleged erroneous refund of accumulated Input Tax Credit. showcased positive momentum across its operations in a recent discussion on CNBC-TV18, spotlighting its first innovative New Drug Application (NDA) approval in the dermatology space and robust progress in its strategic Penicillin G (Pen-G) manufacturing. Aurobindo Pharma Q3 FY26 Performance Summary Aurobindo Pharma announced its financial and operational performance for the third quarter of FY26 (ending December 31, 2025). Our Products Who We Are News Social Responsibility Aurobindo’s partnerships provide ongoing support in times of need. such as generic name of drug, trade name, how to use, its price and composition. , demonstrating a robust pipeline and regulatory progress. Following the disclosure, Aurobindo Pharma’s shares came under pressure as investors reacted to the heightened regulatory scrutiny. 83 crore from the Goods and Services Tax (GST) Department over refunds granted earlier to the company, according to an exchange filing. Aurobindo Pharma Limited Aurobindo Pharma Limited, based in Hyderabad, produces generic medicines for infections, cardiovascular, and central nervous system disorders. Aurobindo Pharma Ltd (BOM:524804) started operations at the PenG plant, with production poised to contribute significantly to profitability as capacity utilization increases. The inspection formed part of the US FDA’s routine oversight of overseas manufacturing sites supplying products to the US market. Vertically integrated supply chain ensures unmatched quality & value for our customers. Listed information related to medicines that are manufactured by Aurobindo Pharma Ltd. Court records for this case are available from Delaware District. Hyderabad: Aurobindo Pharma Limited has informed that the Goods and Services Tax Department has passed orders demanding recovery of refunds earlier granted to the company, with the total disputed The company focuses on launching scientifically advanced products to address unmet needs and deliver value to patients and healthcare stakeholders. 4% year-on-year increase in consolidated revenue for Q3 FY26, reaching INR8,640 crores, driven by strong performance in European operations and stable US business. They said that Bhalla brings more than 25 years of experience across sales, marketing and general management roles. The approved product is ADQUEY™ (difamilast 1%) Ointment. Consolidated revenue grew by 8. Discover Aurobindo Pharma's world-class manufacturing capabilities, advanced facilities, and commitment to quality in global pharmaceutical production. 00 | Buy this Report Now AUROPHARMA Price: Get Aurobindo Pharma stock price on NSE today with Market Cap, Performance, Fundamentals, Shareholding, Financial/Annual report, company profile, quarterly results, & more Acrotech Biopharma Inc (“Acrotech”) a step-down subsidiary of Aurobindo Pharma Ltd, India was formed as a global platform to commercialize innovative proprietary medications. The share of this company, which focuses on generic and speciality pharmaceuticals, including antibiotics Share price of Aurobindo Pharma hit an over three-month low at ₹1,110. On 07/06/2018 Celgene Corporation filed an Intellectual Property - Patent court case against Aurobindo Pharma Limited in U. The disputed amount includes ₹84. Discover Aurobindo Pharma’s commitment to quality, innovation, and affordability. Trade Data Pro platform for HS code, importer exporter records, customs shipment details Aurobindo Pharma Limited issued a clarification to NSE and BSE on February 18, 2026, regarding news reports about a US FDA inspection at Unit-VII. Medication Guides Filter alphabetically A B C D E F G I L M N P R S T V Z Therapeutic Class Brand Equivalent Product Form Sort by Aurobindo Generic Name Brand Name Found 204 Results Page 1 of 5 Aurex BV, Aurobindo Pharma ltd or its subsidiaries does not accept any liability whatsoever for the content of this document or for the consequences of any actions taken on the basis of the information provided through our product list. 6 before retreating. Aurobindo Pharma Usa Trade Data from global. karcor, 9env, qr6suo, r0cw4a, 6tvg, r91bo, cpaqa, p53s, jypu, n9ug,